• Air Traffic Control
  • Govt Finance Report
  • Pension Reform
  • Events
  • Reason facebook
  • Reason twitter
  • Reason youtube
Reason Foundation
  • About
    • About Us
    • Contact Us
    • Email Newsletters
    • Events
    • FAQs
    • Jobs & Internships
    • Savas Award
    • Shop
    • Staff
    • Trustees & Officers
  • Experts

      Browse Our Experts

      • Aaron Smith
        Director of Education Reform
      • Adrian Moore
        Vice President of Policy
      • Baruch Feigenbaum
        Senior Managing Director, Transportation Policy
      • Geoff Lawrence
        Research Director
      • Guy Bentley
        Director of Consumer Freedom
      • Leonard Gilroy
        Vice President of Government Reform
      • Robert Poole
        Director of Transportation Policy
      • Vittorio Nastasi
        Director of Criminal Justice Policy
      • View All Experts
  • Topics

      Browse Our Topics

      • Air Traffic Control
      • Annual Highway Report
      • Consumer Freedom
      • Criminal Justice Reform
      • Drug Policy
      • Education
      • Gov’t Financial Transparency
      • Pension Reform
      • Technology
      • Transportation
      • Urban Growth and Land Use
      • View All Topics
  • Publications
    • Latest
    • Government Financial Project
    • Annual Highway Report
    • Annual Pension Report
    • Annual Privatization Report
    • Aviation Newsletter
    • Backgrounders
    • Commentaries
    • Data Visualization
    • Education Newsletter
    • Email Newsletters
    • Pension Reform Newsletter
    • Policy Studies
    • Psychedelics Newsletter
    • Public Schools Without Boundaries
    • Testimony
    • Transportation Newsletter
    • Amicus Briefs
  • Reason.com
  • Donate
    • Donate Online
    • Donate Crypto
    • Ways To Give
    • Torchbearer Society
    • Planned Giving

Policy Briefs

View all policy studies.

  • Psychedelic treatment for neurodegenerative disorders
    Psychedelic treatment for neurodegenerative disorders

    Recent research suggests that psychedelics, such as psilocybin and LSD, show strong potential as effective treatments for neurodegenerative disorders.

    By Madison Carlino
    January 9, 2025

  • Vision Zero and Complete Streets: Do they make roads safer?
    Vision Zero and Complete Streets: Do they make roads safer?

    In the wake of rising traffic fatalities, municipalities have been looking for a comprehensive solution to reduce or eliminate traffic fatalities.

    By Jay Derr
    October 8, 2024

  • The case for Connecticut’s fiscal guardrails
    The case for Connecticut’s fiscal guardrails

    The “fiscal guardrails” have saved Connecticut more than $170 million and could save $7 billion over the next 25 years.

    By Mariana Trujillo, Jordan Campbell, Steve Vu and Truong Bui
    September 26, 2024

  • A framework for federal and state hemp-derived cannabinoid regulation
    A framework for federal and state hemp-derived cannabinoid regulation

    The growing popularity of hemp-derived products has stimulated significant legislative attention in recent years, with over 90 regulatory proposals introduced in state legislatures in 2024 alone.

    By Michelle Minton and Geoffrey Lawrence
    September 19, 2024

  • Transparent K-12 open enrollment data matters to parents, policymakers and taxpayers
    Transparent K-12 open enrollment data matters to parents, policymakers and taxpayers

    A total of 16 states have strong statewide cross-district open enrollment laws, while 13 states have strong statewide within-district open enrollment laws.

    By Jude Schwalbach
    July 18, 2024

  • Reforming environmental litigation
    Reforming environmental litigation

    There is growing bipartisan support that the NEPA process, as it has evolved since the legislation’s enactment in 1970, has gone too far, placing obstacles and delays in the way of needed energy and transportation infrastructure projects.

    By Robert Poole
    June 26, 2024

  • Is private equity a public financial hazard?
    Is private equity a public financial hazard?

    Private equity funds lack clear return and risk metrics, making it hard to assess performance before investments are redeemed, often a decade or more after the initial investment.

    By Larry Pollack
    June 6, 2024

  • Getting cannabis legalization right in Hawaii
    Getting cannabis legalization right in Hawaii

    Hawaii may be poised to become the 25th state to legalize the recreational use of cannabis for adults aged 21 and over.

    By Michelle Minton and Geoffrey Lawrence
    March 29, 2024

  • Ibogaine treatment for opioid use disorder
    Ibogaine treatment for opioid use disorder

    Policymakers should consider ibogaine as a potential alternative treatment for opioid use disorder.

    By Madison Carlino
    March 15, 2024

  • The effects of cash bail on crime and court appearances
    The effects of cash bail on crime and court appearances

    Research suggests that curtailing the use of monetary release conditions among low-risk defendants would not result in dramatic drops in court attendance or increased risk of reoffending.

    By Vittorio Nastasi
    March 12, 2024

  • A policy framework for personal psychedelics licenses
    A policy framework for personal psychedelics licenses

    Psychedelic licenses for consumers have advantages over the current approach in two U.S. states that rely on professionals to dispense and facilitate services.

    By Gregory Ferenstein
    February 22, 2024

  • The implications of federal cannabis rescheduling
    The implications of federal cannabis rescheduling

    While the optimal solution would be to remove cannabis from the list of controlled substances entirely, moving it to Schedule III presents both immediate and long-term advantages over its current Schedule I designation.

    By Michelle Minton
    January 23, 2024

  • Grading every state’s telehealth laws 
    Grading every state’s telehealth laws 

    While many state telehealth laws changed during the COVID-19 pandemic, some of those reforms have expired and many best practices that would improve health care and help patients still need to be implemented.

    By Vittorio Nastasi, Josh Archambault and Ally Perkins
    January 23, 2024

  • The case for interstate marijuana commerce right now
    The case for interstate marijuana commerce right now

    Pathways to establishing an interstate marketplace for marijuana.

    By Geoffrey Lawrence and Michelle Minton
    January 23, 2024

  • FTC’s lawsuit against Facebook is a test case for path-breaking interpretation of antitrust policy
    FTC’s lawsuit against Facebook is a test case for path-breaking interpretation of antitrust policy

    If the FTC can convince the courts that Facebook’s allegedly anticompetitive behavior has damaged the market, the default solution is nothing short of the dismantling of the company.

    By Thomas Hazlett
    November 16, 2023

  • The importance of North Carolina’s ports and how to improve them
    The importance of North Carolina’s ports and how to improve them

    This policy report examines the roles ports play in North Carolina’s economy, as well as how they are operated.

    By Jay Derr
    November 7, 2023

  • Five actions transit agencies should take in the next two years
    Five actions transit agencies should take in the next two years

    With transit ridership down, most large transit agencies will likely face a severe financial cliff in late 2024 when federal stimulus funds have been depleted.

    By Baruch Feigenbaum
    September 20, 2023

  • California’s Age-Appropriate Design Code Act threatens the foundational principle of the internet
    California’s Age-Appropriate Design Code Act threatens the foundational principle of the internet

    The AADC’s age assurance requirement erects onerous barriers that would discourage internet use and chill protected speech.

    By Eric Goldman and Adrian Moore
    September 7, 2023

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • ...
  • 21
  • Next

Follow

  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS

Email Updates

Get weekly updates from Reason.

This field is for validation purposes and should be left unchanged.

More About Reason Foundation

  • About
  • Contact
  • Donate
  • Email Newsletters
  • Events
  • Jobs and Internships
  • Policy Research
  • Reason magazine
  • Shop

Contact

Reason Foundation
5737 Mesmer Ave.
Los Angeles, CA 90230
(310) 391-2245

1630 Connecticut Ave NW
Suite 600
Washington, DC 20009
(202) 986-0916

Privacy Policy
Accessibility

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
Copyright © 2025 Reason Foundation